Responses of acrylamide-treated rat bladders

Area of Science:

• Toxicology
• Urology
• Pharmacology

Background:

• Acrylamide (ACR) is an industrial chemical and a food contaminant.
• ACR is a known neurotoxicant, reproductive toxicant, and carcinogen in animal models.
• Its effects on the urinary bladder, particularly concerning contractile responses and tissue integrity, require further investigation.

Purpose of the Study:

• To investigate the impact of ACR exposure on rat urinary bladder contractility.
• To assess ACR's influence on receptor-dependent (carbachol) and receptor-independent (KCl) contractions.
• To examine potential gender-specific differences in ACR-induced urinary bladder effects.

Main Methods:

• Rats of both genders were administered ACR daily for 90 days at doses of 2 mg/kg/d (ACR-I) or 5 mg/kg/d (ACR-II).
• Control groups received no ACR treatment.
• Urinary bladder responses to cumulative concentrations of carbachol and KCl were measured and analyzed.

Main Results:

• ACR treatment significantly increased the EC50 values for both carbachol and KCl, indicating reduced bladder sensitivity.
• No significant changes were observed in the maximal contractile responses to carbachol or KCl.
• Histopathological examination revealed increased edema, inflammation, fibrosis, and epithelial damage in ACR-treated bladders compared to controls.

Conclusions:

• ACR exposure induces significant urinary bladder injury in rats.
• The functional and structural damage suggests a detrimental effect of ACR on bladder physiology.
• These findings underscore the potential risks associated with ACR exposure to the urinary system.